Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.7K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.7K
Growth of Cartilage and Bone Tissue01:27

Growth of Cartilage and Bone Tissue

3.7K
Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial.

Nature medicine·2026
Same author

Childhood Cancer Data Initiative Participant Index: Mapping Pediatric Cancer Data to Facilitate Cross-Study Integrated Analysis.

JCO clinical cancer informatics·2026
Same author

Rare cancers research: Current state of knowledge and emerging opportunities for prevention and interception.

Journal of the National Cancer Institute·2026
Same author

BRAF V600E Expression in c-Kit+ Interstitial Cells of Cajal Drives Gastrointestinal Stromal Tumor Formation in Mice.

Cancer research communications·2026
Same author

T<sub>1</sub>ρ Magnetic Resonance Fingerprinting in Patients With Chronic Pancreatitis.

Journal of magnetic resonance imaging : JMRI·2026
Same author

Erratum: Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Related Experiment Video

Updated: Oct 28, 2025

Endoscopic Cholesteatoma Surgery
08:47

Endoscopic Cholesteatoma Surgery

Published on: January 19, 2022

11.3K

Chordoma: Current status, problems, and future directions.

Mary Frances Wedekind1, Brigitte C Widemann1, Gregory Cote2

  • 1Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Current Problems in Cancer
|July 16, 2021
PubMed
Summary
This summary is machine-generated.

Chordoma, a rare axial spine tumor, often relapses or metastasizes despite slow growth, necessitating better understanding for effective chordoma treatments.

Keywords:
ChordomaConventional chordomaDedifferentiated chordomaImmunotherapyPoorly differentiated chordoma

More Related Videos

Visualization of Chondrocyte Intercalation and Directional Proliferation via Zebrabow Clonal Cell Analysis in the Embryonic Meckel&#8217;s Cartilage
06:40

Visualization of Chondrocyte Intercalation and Directional Proliferation via Zebrabow Clonal Cell Analysis in the Embryonic Meckel’s Cartilage

Published on: October 21, 2015

9.2K
Surgical Treatment of an Endolymphatic Sac Tumor
04:34

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

993

Related Experiment Videos

Last Updated: Oct 28, 2025

Endoscopic Cholesteatoma Surgery
08:47

Endoscopic Cholesteatoma Surgery

Published on: January 19, 2022

11.3K
Visualization of Chondrocyte Intercalation and Directional Proliferation via Zebrabow Clonal Cell Analysis in the Embryonic Meckel&#8217;s Cartilage
06:40

Visualization of Chondrocyte Intercalation and Directional Proliferation via Zebrabow Clonal Cell Analysis in the Embryonic Meckel’s Cartilage

Published on: October 21, 2015

9.2K
Surgical Treatment of an Endolymphatic Sac Tumor
04:34

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

993

Area of Science:

  • Oncology
  • Genetics

Background:

  • Chordoma is a rare tumor affecting the axial spine in both pediatric and adult populations.
  • Despite a typically slow-growing nature, chordoma frequently leads to loco-regional relapse or metastatic disease.
  • Current treatment options for chordoma remain limited, with a significant unmet need for effective therapies.

Purpose of the Study:

  • To highlight the critical need for enhanced understanding of chordoma biology.
  • To emphasize the potential of detailed subtype analysis for therapeutic development.
  • To underscore the importance of natural history, genomic variability, and age-related differences in chordoma research.

Main Methods:

  • Review of existing literature on chordoma incidence, natural history, and treatment outcomes.
  • Analysis of the impact of tumor location, age, and genomic variability on chordoma progression.
  • Identification of knowledge gaps in understanding chordoma subtypes.

Main Results:

  • Chordoma presents a significant challenge due to its propensity for relapse and metastasis.
  • Limited effective treatments exist, despite over a decade of research efforts.
  • Subtyping chordoma reveals distinct characteristics influencing disease behavior.

Conclusions:

  • A deeper understanding of chordoma subtypes, natural history, and genomic variability is crucial.
  • This enhanced knowledge is essential for designing effective clinical trials and therapies for chordoma patients.
  • Further research into chordoma's complexities may unlock new treatment avenues.